ABSTRACT
The efficacy of lithium prophylaxis in bipolar disorder has been convincingly documented by several double-blind randomized placebocontrolled trials (see reference 1 for a systematic review). However, there are several reasons why the evidence provided by controlled trials can be usefully complemented by the information collected through well-designed observational studies carried out in ordinary clinical conditions.
